ENTITY GLP-1R/GIPR

GLP-1R/GIPR

PulseAugur coverage of GLP-1R/GIPR — every cluster mentioning GLP-1R/GIPR across labs, papers, and developer communities, ranked by signal.

Total · 30d

1

1 over 90d

Releases · 30d

0

0 over 90d

Papers · 30d

0

0 over 90d

TIER MIX · 90D

TOPICS

SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL

TOOL · CL_118254 · Jun 30 · 09:11

Hanmi Pharmaceutical's tirzepatide injection receives FDA acceptance for diabetes and weight loss

Hanmi Pharmaceutical has received acceptance from the U.S. FDA for its abbreviated new drug application (ANDA) for tirzepatide injection, targeting diabetes and weight loss. This drug is a dual-target agonist developed …